Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina Inc (NQ: ILMN )

149.76 +5.62 (+3.90%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina Inc

< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
Extending COVID Surveillance Capabilities Beyond Big Cities
With the debut of Illumina's COVIDSeq Assay, smaller labs are participating in Covid-19 surveillance 
Via News Direct
Exposures COVID-19
Forget Robinhood, These 3 Healthcare Stocks Are Better Buys
Wait for pitches that are easy to hit before taking a swing. 
Via The Motley Fool
What Does the Future Look Like for Illumina Stock?
The leader in the genomics space is being treated like a monopoly, and is now running into federal regulation and oversight. 
Via The Motley Fool
Extending COVID Surveillance Capabilities Beyond Big Cities
SOURCE: Illumina 
Via 3BL Media
Exposures COVID-19
Illumina Donates Next-Generation Sequencing Capabilities to Support Indigenous Scientists
Next-generation sequencing is helping Native nations with sovereignty and genetic research 
Via News Direct
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Illumina Celebrates National Intern Day
SOURCE: Illumina 
Via 3BL Media
Illumina Donates Next-Generation Sequencing Capabilities to Support Indigenous Scientists
SOURCE: Illumina 
Via 3BL Media
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Why Does Illumina Want to Reunite With Grail?
The genomics leader might be hitting a ceiling in its original business. 
Via The Motley Fool
Tesla And eBay Fall As The QQQ Closes Lower
U.S. indices had a mixed day of trading Friday following better-than-expected jobs data. The unemployment rate for July came in at 5.4%, which was below the 5.7%... 
Via Benzinga
Illumina Q2 Earnings Boosted By Robust Growth In Core Sequencing Business; Uplifts FY21 Outlook
lumina Inc reported after the close of the market on Thursday that its second-quarter revenues grew 78% Y/Y to $1.13 billion, beating the consensus of $1.01 billion, driven by strength in its core... 
Via Talk Markets
Illumina Stock Will Be Unstoppable Once the Grail Acquisition Gets Approved
Illumina will likely be allowed to buy Grail. But even without Grail, ILMN stock is very attractive, given its strong growth drivers. 
Via InvestorPlace
Somatic Genetic Testing Market to See Thriving Worldwide : Genomics, Illumina, Invivoscribe
Stay up-to-date with Global Somatic Genetic Testing Market research offered by AMA. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Exposures COVID-19
Illumina Q2 Earnings Boosted By Robust Growth In Core Sequencing Business; Uplifts FY21 Outlook
Illumina Inc (NASDAQ: ILMN) reported after the close of the market on Thursday that its second-quarter revenues grew 78% Y/Y to $1.13 billion, beating the consensus of... 
Via Benzinga
Illumina, inc (ILMN) Q2 2021 Earnings Call Transcript
ILMN earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Illumina: Q2 Earnings Insights
Shares of Illumina (NASDAQ:ILMN) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 201.61% over the past year... 
Via Benzinga
Illumina Stock Dips Late Despite Second-Quarter Beat And Raise
Illumina stock dipped late Thursday after the genetic testing company reported adjusted profit of $1.87 per share on $1.13 billion in sales. 
Via Investor's Business Daily
Illumina Donates $1 Million in Sequencing Capabilities to Mumbai to Support Sequencing-Based COVID-19 Surveillance in India
Illumina Donates $1 Million in Sequencing Capabilities to Mumbai to Support Sequencing-Based COVID-19 Surveillance in India 
Via News Direct
Exposures COVID-19
DNA Sequencing Instruments Market to See Huge Growth by 2026 : Abbott Laboratories, Agilent Technologies, Danaher
Stay up to date with DNA Sequencing Instruments Market research offered by AMA. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Illumina Donates $1 Million in Sequencing Capabilities to Mumbai to Support Sequencing-Based COVID-19 Surveillance in India
SOURCE: Illumina 
Via 3BL Media
Exposures COVID-19
What We Learned About Genetic Sequencing During COVID-19 Could Revolutionize Public Health
What We Learned About Genetic Sequencing During COVID-19 Could Revolutionize Public Health 
Via News Direct
Exposures COVID-19
What We Learned About Genetic Sequencing During COVID-19 Could Revolutionize Public Health
SOURCE: Illumina 
Via 3BL Media
Exposures COVID-19
Illumina Celebrates National Intern Day
Illumina Celebrates National Intern Day 
Via News Direct
3 Things About Illumina That Smart Investors Know
The company is cemented as the industry leader, but a crack is showing. 
Via The Motley Fool
Proteomics Market worth $55.9 billion by 2026
Via AB Newswire
After Naming a New CFO, Is This Genetic Diagnostics Company a Buy?
Veracyte appointed Rebecca Chambers, who boasts a wealth of financial executive experience, to the position. 
Via The Motley Fool
Illumina to Webcast Upcoming Investor Conference
From Illumina, Inc.
Via Business Wire
Illumina Employees are Encouraged to Invest in Themselves With Annual Health and Lifestyle Allowance
Illumina Employees are Encouraged to Invest in Themselves With Annual Health and Lifestyle Allowance 
Via News Direct
Illumina Employees are Encouraged to Invest in Themselves With Annual Health and Lifestyle Allowance
SOURCE: Illumina 
Via 3BL Media
Illumina-Grail $8B Merger Hit By European Commission's In-Depth Investigation
The European Commission has opened an in-depth, three-month investigation into Illumina Inc's (NASDAQ: ILMN) planned takeover of Grail, a deal valued... 
Via Benzinga
The Branford Group to Conduct Auction of Leading Genomic Testing Lab CQuentia in Memphis
The Branford Group ("Branford"), a leader in asset valuation and disposition services, has been engaged by CQuentia to sell the assets of its genomic testing and personalized healthcare facility in... 
Via Newswire.com
Topics Intellectual Property
Exposures Intellectual Property
< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.